Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -12.06
- Piotroski Score 2.00
- Grade Neutral
- Symbol (FREQ)
- Company Frequency Therapeutics, Inc.
- Price $0.30
- Changes Percentage (4.76%)
- Change $0.01
- Day Low $0.28
- Day High $0.32
- Year High $5.59
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/01/2023
- Fiscal Year End N/A
- Average Stock Price Target $7.00
- High Stock Price Target $7.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.90
- Trailing P/E Ratio -0.15768421052632
- Forward P/E Ratio -0.15768421052632
- P/E Growth -0.15768421052632
- Net Income $-81,580,000
Income Statement
Quarterly
Annual
Latest News of FREQ
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
The Zacks Analyst Blog Meta, Cisco, Philip Morris, Earth Science Tech and Frequency Electronics
Zacks.com features stocks like Meta Platforms, Cisco Systems, Philip Morris, Earth Science Tech, and Frequency Electronics in their Analyst Blog. Reports discuss company performance, industry trends, ...
By Yahoo! Finance | 1 day ago -
Opinion | Eric Adams Gives New Meaning to Frequent-Flier Program
Gail Collins and Bret Stephens discuss the controversies surrounding New York's mayor, Eric Adams, and question if accepting perks like discounted flights should lead to resignations. They reflect on ...
By The New York Times | 1 week ago -
Selena Gomez, Kim Kardashian, other celebrities frequent NYC restaurant promoting $1 dessert for a day
Serendipity3, a popular New York restaurant among celebrities, is celebrating 70 years by offering its famous "Frrrozen Hot Chocolate" for just $1 on Sept. 18, harkening back to its 1950s pricing....
By Fox News | 3 weeks ago
